🎲The #EASLQuiz is out! The new EASL - EASD- EASO Guidelines on MASLD were launched this month. 🤔Are you up to date with them? Test your knowledge! 👉https://lnkd.in/ev-e6DHy European Association for the Study of Diabetes e.V. (EASD) European Association for the Study of Obesity (EASO)
EASL | The Home of Hepatology’s Post
More Relevant Posts
-
Join us for what promises to be a fantastic webinar in our Drug Innovations series: learn about the link between type 2 diabetes and obesity, and much more https://lnkd.in/eV_WWqi4
To view or add a comment, sign in
-
-
New research from the Look AHEAD trial shows increasing moderate-to-vigorous physical activity can significantly reduce the risk of chronic kidney disease in people with type 2 diabetes and obesity. Stay active, stay healthy! #CKDPrevention #DiabetesCare #PhysicalActivity
To view or add a comment, sign in
-
-
In the latest episode of our video series Gamechangers, Professor John Buse reflects on what a paper comparing tirzepatide and semaglutide means for the future of the obesity pandemic and people with type 2 diabetes. Watch the clip on our site: https://lnkd.in/epgpdZPF #diabetes #type2diabetes #t2d #obesity
To view or add a comment, sign in
-
-
Researchers re-analysed the evidence EFSA used to declare a link between ‘fruit juice’ and risk of type 2 diabetes and higher body weight. They found NO SIGNIGICANT ASSOCATION between 100% fruit juice and type 2 diabetes incidence and NO LINK between 100% fruit juice and abdominal obesity incidence. Find out why in our summary: 👉 https://lnkd.in/emUqFhbB
To view or add a comment, sign in
-
-
Understanding the role of glucose-dependent insulinotropic polypeptide in managing diabetes and obesity https://lnkd.in/eb3HQXNY https://lnkd.in/eiPY3PUs
To view or add a comment, sign in
-
-
The SELECT trial reveal that there are many mechanisms of semaglutide that could attribute for cardiovascular and obesity benefit (cardiovascular benefit, liver disease and inflammatory) independent of weight loss, ➡️hence this make it unwise to stop this medication once achieving target weight loss. ➡️Lack of heterogeneity in achieving primary composite endpoints within different subgroups ➡️achieving clinical significance and numerical reduction in all cause mortality. ➡️economical value is challenging ➡️previous supportive evidence for weight loss independent CVS protective actions of the GLP-1 agonist as in HARMONY Outcomes trial for Albiglutide in type 2 DM there was no body weight difference at 28 weeks, yet 22% reduction in MACE, driven by fewer MI events https://lnkd.in/e98ZtQGF
SELECT trial results presented at #AHA23 show in adults with overweight or obesity who do not have diabetes, semaglutide reduced the risk of major adverse cardiovascular events by 20%.
To view or add a comment, sign in
-
-
This is such a big thing. Results of a study just published. Semaglutide is a DIABETES medication in origin. But it's effects are so beneficial that now it can be a WEIGHT management medication in the overweight or obese patient profile with prior cardiovascular disease (even if you don't have diabetes). Proven to reduce the combination end point of cardiovascular deaths, non fatal heart attacks and strokes. #cardiology #weightloss #lifestyle
SELECT trial results presented at #AHA23 show in adults with overweight or obesity who do not have diabetes, semaglutide reduced the risk of major adverse cardiovascular events by 20%.
To view or add a comment, sign in
-
-
Thanking the Northeast Business Group on Health for sharing their recently released resource, "Cardiovascular Disease, Diabetes and Obesity in Women: A Guide for Employers." To view additional resources on these topics, check out MBGH's resource page: https://lnkd.in/dxeZibPc. #employers #hr #healthbenefits #hearthealth #diabetes #obesity
Today are thrilled to announce the release of "Cardiovascular Disease, Diabetes and Obesity in Women: A Guide for Employers"! Check it out:
To view or add a comment, sign in
-
September is National Childhood Obesity Awareness Month. According to the CDC, about 1 in 5 American children has obesity. These children are at a higher risk for asthma, sleep apnea, bone and joint problems, type 2 diabetes, and risk factors for heart disease such as high blood pressure. Explore our diabetes & obesity resources here: bit.ly/3POaAdP #ChildhoodObesityAwarenessMonth #ChildhoodObesityMonth #ChildhoodObesity #ObesityResearch
Diabetes & Obesity
alpco.com
To view or add a comment, sign in
-
𝗛𝗲𝗮𝗹𝘁𝗵 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗼𝗳 #Mushrooms -Has Anti-Inflammatory Properties -May Help Diabetes Prevention and Treatment -Offers Obesity Support -May Improve Blood Pressure Regulation -May Reduce Depression Risk -Supports Brain Health -Offers Immune Support -May Help Protect Against Cancer Source https://loom.ly/xVYIoMs
To view or add a comment, sign in
-